Long-term drug treatment for obesity: a systematic and clinical review - Wikidata - awgldk - TriplyDB

Long-term drug treatment for obesity: a systematic and clinical review

Long-term drug treatment for obesity: a systematic and clinical review

http://www.wikidata.org/entity/Q22253010

about

Long-term effects of weight-reducing drugs in people with hypertension Current status of intragastric balloon for obesity treatment Review: Miglitol has potential as a therapeutic drug against obesity Obesity and liver transplantation Acupoint Catgut Embedding for Obesity: Systematic Review and Meta-Analysis The long-term effect of energy restricted diets for treating obesity Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies.Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular Complications Calcium Sensing Receptor as a Novel Mediator of Adipose Tissue Dysfunction: Mechanisms and Potential Clinical Implications Next generation of weight management medications: implications for diabetes and CVD risk Peripheral signals mediate the beneficial effects of gastric surgery in obesity Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences Drug interventions for the treatment of obesity in children and adolescents Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization Dietary capsaicin and its anti-obesity potency: from mechanism to clinical implications.Medical Management of Diabesity: Do We Have Realistic Targets?Anti-obesogenic and antidiabetic effects of plants and mushrooms.Obesity: Current and potential pharmacotherapeutics and targets.Body mass index: Has epidemiology started to break down causal contributions to health and disease?A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice.Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.Weight Management in Older Adults.A systematic review and narrative synthesis of interventions for uncomplicated obesity: weight loss, well-being and impact on eating disorders.Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice Optimal management of subfertility in polycystic ovary syndrome.Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway.Management of obesity in the psychiatrist's office.Homeostasis in anorexia nervosa.Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Quantifying energy intake changes during obesity pharmacotherapy.Obesity in kidney disease: A heavyweight opponent.Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial.Impact of long-term lifestyle programmes on weight loss and cardiovascular risk factors in overweight/obese participants: a systematic review and network meta-analysis Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys FXR: the key to benefits in bariatric surgery?Oxytocin reduces caloric intake in men The supplementation effects of peanut sprout on reduction of abdominal fat and health indices in overweight and obese women.The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA

P2860

Q24186054-D4921F37-E01D-475C-8DA4-51E879795271 Q26746920-5DA2DC4E-375C-4582-8C59-01E0276245BB Q26775478-CB26EE9C-F53D-4F04-97F3-0F50B9D81C09 Q26784097-0AC3498F-77D7-4450-B99F-417D81EEA60D Q26784635-8F040EA6-B736-4D92-9A0B-04A7D407830F Q26801142-C7625042-BBC8-4EC7-AC1F-95C000D8CC06 Q27023275-5F963EE1-ACDF-4AF8-9D77-694BC5F2428F Q27331844-2B3A5D87-85ED-47B1-AC72-702A3EFC5440 Q28069452-3034A6F3-633C-46A6-BD40-259206882558 Q28077092-A38D230E-6681-4E29-BBAF-9915D2BE38E4 Q28082858-90D7AA46-9C6F-4DFA-A3BC-587239DDD72D Q28088425-495E8768-8F6E-46A6-BF79-B150DE4BB4AC Q28088815-9B5CAD44-FD0B-4E1E-90BD-2FF716556303 Q28279770-77EBAAAA-0CA3-42FD-810A-463681088D8E Q28550545-DB20700C-3E0F-496B-BC06-604B5C3F7FCA Q30234738-06322DE5-70E8-471F-99E5-24E4838F6416 Q30238940-CC16B8BC-04D4-4E18-9AB9-99BD342B0B8C Q30241950-41D7D54B-7F24-48FF-8BBC-28BBCC8283A0 Q30243992-60C6D451-D1F5-4250-9A12-78747E4D6885 Q30248778-B4B5633B-3645-402D-8814-F6AB24AE8383 Q30387831-0EAD0E2A-7C5B-46F1-8EB5-A239516E8471 Q30400748-48E40047-05AE-49E7-BF08-C8A4212C34AF Q33551880-E3BB8CB3-118D-471F-A4BC-277819308282 Q33619779-D96ABA5A-BF47-4E81-A682-F1B20E6F499A Q33693962-AB3AFFDC-2D0E-42DC-9D80-CB9B32AB3404 Q33779073-A729ED79-B491-4746-8CC0-F158E8706FE0 Q33783700-3C941774-4974-4967-B684-E43E1274DAF1 Q33915520-C32C1F20-F979-4A1A-808A-403BCA3B49A4 Q34009868-CA120544-7879-41A5-8593-0E48411C906E Q34248044-7CC6B925-3CCD-4ADC-B758-0D9AF714C568 Q34270377-C116A185-DDD6-46A1-A3F1-56ACCA90705F Q34367664-0ABBD1B2-F89C-492A-9FA6-E30BA753EAE5 Q34465313-29665021-1BF6-4884-A1E4-C025EA3333DC Q34490685-34F0A03F-0D38-44A6-A132-4BB56C653538 Q34637579-ED51AB17-B654-42AB-918B-8E1B2A9C160F Q35138545-8719903E-1EC2-4CEC-971C-BDE05C9221C7 Q35142008-A9E7F07C-5D96-4849-8CB6-D9A239041A08 Q35554159-3B21081E-F218-4F6D-A611-5369FC379BD1 Q35696804-AFAF6D2A-A92D-43D8-AF5A-3B939988F2B2 Q35801505-CE8763CC-D716-4BD8-9218-28611C96EDEA

P2860

Long-term drug treatment for obesity: a systematic and clinical review

http://www.wikidata.org/entity/Q22253010

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Long-term drug treatment for obesity: a systematic and clinical review

@ast

Long-term drug treatment for obesity: a systematic and clinical review

@en

Long-term drug treatment for obesity: a systematic and clinical review

@en-gb

Long-term drug treatment for obesity: a systematic and clinical review

@nl

type

label

Long-term drug treatment for obesity: a systematic and clinical review

@ast

Long-term drug treatment for obesity: a systematic and clinical review

@en

Long-term drug treatment for obesity: a systematic and clinical review

@en-gb

Long-term drug treatment for obesity: a systematic and clinical review

@nl

prefLabel

Long-term drug treatment for obesity: a systematic and clinical review

@ast

Long-term drug treatment for obesity: a systematic and clinical review

@en

Long-term drug treatment for obesity: a systematic and clinical review

@en-gb

Long-term drug treatment for obesity: a systematic and clinical review

@nl

P1433

Q22253010-FDE013E1-D42C-425C-8659-63DDEAF35783

P1476

Q22253010-A61629C0-028F-4518-A67E-7C698C6304A3

P2093

Q22253010-F619AF29-5A81-4DCA-8439-46CF3AC9EF10

P2860

Q22253010-01B6E75A-1FB1-4B14-8D0B-2EC2F87A952C

Q22253010-1C8AD2BF-1C81-4B84-A376-00244B03B7BE

Q22253010-1DC27859-3273-4023-A2AD-17CBE9248751

Q22253010-1E125C97-91AB-49BF-8695-794CED1F43C0

Q22253010-1E534954-D816-49B2-9C85-93C18AE84166

Q22253010-22885CB6-B4B1-458A-A5E3-2F63DA037293

Q22253010-3A7550B4-AE00-4A80-BCE1-056B5B530EF2

Q22253010-42BAA4E7-6283-40BA-AD76-1D1A9982A3B2

Q22253010-45457849-8FB1-4EBB-B4DD-A8ECCCF18920

Q22253010-484F9635-C3DC-4CCA-B6A6-B678C199F672

P304

Q22253010-956A9BC2-CC41-4758-80DA-A0C7E5689D75

P31

Q22253010-D6922546-C3D7-4551-ADE2-8EBCDAEC1B5A

P3181

Q22253010-EA15C50A-635F-46D6-AB25-C82123DD1BF1

P356

Q22253010-E5479D32-1EA7-4B20-9B05-F832808C22BB

P407

Q22253010-CAD60F27-C088-43F4-A91A-FFBFAAC6F995

P433

Q22253010-3D04AD8C-A36D-4289-ACBC-A58D445A8205

P478

Q22253010-E2E544F6-F0E8-4F9E-946E-1CA600FA138F

P50

Q22253010-32A9EFB1-2A23-4689-A497-F0FCBA138A86

P577

Q22253010-37F6975F-1E54-4E45-8903-3A21C9FFC032

P5875

Q22253010-80F53709-BA37-4076-AC13-43AD3067E642

P698

Q22253010-EAE5F4C0-22C0-42D2-9756-DC718AB0449F

P921

Q22253010-8F33B270-ED72-4B33-979A-3CA8AC1FF257

P932

Q22253010-1D1766EA-2247-4D83-869C-C9584302FDFE

P3181

P356

JAMA.2013.281361

P1433

Journal of the American Medical Association

P1476

Long-term drug treatment for obesity: a systematic and clinical review

@en

P2093

Susan Z Yanovski

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for and Management of Obesity in Adults: U.S. Preventive Services Task Force Recommendation Statement

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Antidepressants and Body Weight

Managing obesity in primary care practice: an overview with perspective from the POWER-UP study

Valvular heart disease associated with fenfluramine-phentermine

Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes

New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach

P304

74-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1419569

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2013.281361

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P50

Jack A Yanovski

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258527086

http://www.w3.org/2001/XMLSchema#string

P698

24231879

http://www.w3.org/2001/XMLSchema#string

P921

P932

3928674

http://www.w3.org/2001/XMLSchema#string